首页> 外文期刊>Nature >Human oocytes reprogram somatic cells to a pluripotent state
【24h】

Human oocytes reprogram somatic cells to a pluripotent state

机译:人类卵母细胞将体细胞重编程为多能状态

获取原文
获取原文并翻译 | 示例
       

摘要

The exchange of the oocyte's genome with the genome of a somatic cell, followed by the derivation of pluripotent stem cells, could enable the generation of specific cells affected in degenerative human diseases. Such cells, carrying the patient's genome, might be useful for cell replacement. Here we report that the development of human oocytes after genome exchange arrests at late cleavage stages in association with transcriptional abnormalities. In contrast, if the oocyte genome is not removed and the somatic cell genome is merely added, the resultant triploid cells develop to the blastocyst stage. Stem cell lines derived from these blastocysts differentiate into cell types of all three germ layers, and a pluripotent gene expression program is established on the genome derived from the somatic cell. This result demonstrates the feasibility of reprogramming human cells using oocytes and identifies removal of the oocyte genome as the primary cause of developmental failure after genome exchange.
机译:将卵母细胞的基因组与体细胞的基因组进行交换,然后衍生多能干细胞,可以使受退化性人类疾病影响的特定细胞生成。携带患者基因组的此类细胞可能对细胞置换有用。在这里,我们报告人类基因组交换后卵母细胞的发育在卵裂后期与转录异常有关。相反,如果不除去卵母细胞基因组而仅添加体细胞基因组,则所产生的三倍体细胞发展到胚泡阶段。源自这些胚泡的干细胞系分化为所有三个胚层的细胞类型,并且在源自体细胞的基因组上建立了多能基因表达程序。该结果证明了使用卵母细胞对人细胞进行重编程的可行性,并鉴定了卵母细胞基因组的去除是基因组交换后发育失败的主要原因。

著录项

  • 来源
    《Nature》 |2011年第7367期|p.70-75|共6页
  • 作者单位

    The New York Stem Cell Foundation Laboratory, New York, New York, USA;

    Department of Bioengineering, University of California at San Diego, La Jolla, California, USA;

    Department of Bioengineering, University of California at San Diego, La Jolla, California, USA;

    The New York Stem Cell Foundation Laboratory, New York, New York, USA;

    Center for Women's Reproductive Care, College of Physicians and Surgeons, Columbia University, New York, New York, USA;

    Center for Women's Reproductive Care, College of Physicians and Surgeons, Columbia University, New York, New York, USA;

    Center for Women's Reproductive Care, College of Physicians and Surgeons, Columbia University, New York, New York, USA;

    The New York Stem Cell Foundation Laboratory, New York, New York, USA;

    The New York Stem Cell Foundation Laboratory, New York, New York, USA;

    Department of Obstetrics and Gynecology, College of Physicians and Surgeons, Columbia University, New York, New York, USA;

    Department of Obstetrics and Gynecology, College of Physicians and Surgeons, Columbia University, New York, New York, USA;

    Department of Bioengineering, University of California at San Diego, La Jolla, California, USA;

    Department of Obstetrics and Gynecology, College of Physicians and Surgeons, Columbia University, New York, New York, USA;

    Center for Women's Reproductive Care, College of Physicians and Surgeons, Columbia University, New York, New York, USA;

    Department of Obstetrics and Gynecology, College of Physicians and Surgeons, Columbia University, New York, New York, USA;

    The New York Stem Cell Foundation Laboratory, New York, New York, USA;

  • 收录信息 美国《科学引文索引》(SCI);美国《工程索引》(EI);美国《生物学医学文摘》(MEDLINE);美国《化学文摘》(CA);
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

  • 入库时间 2022-08-18 02:54:49

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号